Drug interactions between ribociclib and Slow Fe with Folic Acid
|Slow Fe with Folic Acid (ferrous sulfate/folic acid)|
Interactions between your drugs
There were no interactions found in our database between ribociclib and Slow Fe with Folic Acid - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Ribociclib is in the drug class CDK 4/6 inhibitors.
- Ribociclib is used to treat the following conditions:
Slow Fe with Folic Acid
A total of 180 drugs are known to interact with Slow Fe with Folic Acid.
- Slow Fe with Folic Acid is a member of the following drug classes: iron products, vitamin and mineral combinations.
- Slow Fe with Folic Acid is used to treat Iron Deficiency Anemia.
Drug and food interactions
Applies to: ribociclib
Patients should not consume pomegranates, pomegranate juice, grapefruit, or grapefruit juice during treatment with ribociclib unless directed otherwise by your doctor. Pomegranate juice or grapefruit juice can increase the blood levels of ribociclib. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; abdominal pain; mouth sores; hair loss; weakness; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
ferrous sulfate food
Applies to: Slow Fe with Folic Acid (ferrous sulfate / folic acid)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|